(Q68003639)
Statements
Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group study (English)
G K Ellis
S Green
S Schulman
C A Coltman
H E Hynes
S Rivkin
R B Livingston
1 September 1991